cta-logo01
  • News

    Most Read

    • Takeda doses first subject in Japanese Covid-19 vaccine trial
    • Regeneron’s antibodies demonstrate promise against MERS-CoV in NIH trial
    • Ireland’s ICON signs agreement to acquire PRA Health Sciences

    Most Recent

    Clinical Trials

    Takeda doses first subject in Japanese Covid-19 vaccine trial

    25 Feb 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Neurology trends: Stroke leads Twitter mentions in Q4 2020
    • InSilicoTrials: accelerating the uptake of simulation in clinical research
    • Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy

    Most Recent

    Neurology

    Neurology trends: Stroke leads Twitter mentions in Q4 2020

    24 Feb 2021
  • Sectors

    Sections

    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices

    Most Read

    • Takeda doses first subject in Japanese Covid-19 vaccine trial
    • Regeneron’s antibodies demonstrate promise against MERS-CoV in NIH trial
    • Ireland’s ICON signs agreement to acquire PRA Health Sciences

    Most Recent

    Clinical Trials

    Takeda doses first subject in Japanese Covid-19 vaccine trial

    25 Feb 2021
  • Themes
  • Deals

    Most Read

    • Altasciences completes acquisition of US-based CRO WCCT Global
    • Investment firm GI Partners closes Clinical Ink acquisition
    • Investment firm GI Partners to acquire minority interest in Clinical Ink

    Most Recent

    Clinical Trials

    Altasciences completes acquisition of US-based CRO WCCT Global

    19 Feb 2021
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Kolabtree
    • VaLea Clinical Trials
    • Linari NanoTech

    Most Recent

    Clinical Trials

    Kolabtree

    24 Feb 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register

Aeromics starts Phase l trial of AER-271 for stroke

Aeromics has begun a Phase l clinical trial of AER-271 to treat severe ischemic stroke.

10th July 2018

Latest News

Clinical Trials

Constant Therapeutics’ drug enters Phase II trial for Covid-19 in Israel

25 Feb 2021
Clinical Trials

Takeda doses first subject in Japanese Covid-19 vaccine trial

25 Feb 2021
Clinical Trials

Regeneron’s antibodies demonstrate promise against MERS-CoV in NIH trial

24 Feb 2021
Clinical Trials

Ireland’s ICON signs agreement to acquire PRA Health Sciences

24 Feb 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
CTArena_white-logo_

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more